Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease

Muscle and Nerve

Volumn 30, Issue 1, 2004, Pages 69-76

  Chetlin, Robert D ^a   Gutmann, Laurie ^b   Tarnopolsky, Mark A ^c   Ullrich, Irma H ^b   Yeater, Rachel A ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Charcot Marie Tooth disease; Creatine; Exercise; Nutritional supplement

Indexed keywords

CREATINE; NEOTINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENERGY METABOLISM; EXERCISE; FEMALE; FUNCTIONAL ASSESSMENT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN TISSUE; MALE; METABOLITE; MUSCLE CELL; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACTIVITIES OF DAILY LIVING; ADULT; BIOPSY; CHARCOT-MARIE-TOOTH DISEASE; COMBINED MODALITY THERAPY; CREATININE; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PATIENT COMPLIANCE;

EID: 3042774915     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20078     Document Type: Article

References (30)

1. Aitkens S, McCrory M, Kilmer D, Bernauer E. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1993;74:711-715.
2. Andres P, Thibodeau L, Finison L, Munsat T. Quantitative assessment of neuromuscular deficit in ALS. Neurol Clin 1987;5:125-141.
3. Bergstrom J. Muscle electrolytes in man. J Clin Lab Invest 1962;14(Suppl 68):1-110.
4. Borg K, Ericson-Gripenstedt. Muscle biopsy abnormalities differ between Charcot-Marie-Tooth type 1 and 2: reflect different pathophysiology? Exerc Sport Sci Rev 2002;30:4-7.
5. Brooke M, Kaiser K. Three "myosin adenosine triphosphatase" systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cyochem 1970;18:670-672.
6. Brose A, Parise G, Tarnopolsky M. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol Biol Sci 2003;58:11-19.
7. Chance P, Pleasure D. Charcot-Marie-Tooth syndrome. Arch Neurol 1993;50:1180-1184.
8. Doherty T, Lougheed K, Markez J, Tarnopolsky M. Creatine monohydrate does not increase strength in patients with hereditary neuropathy. Neurology 2001;57:559-560.
9. Dubowitz V, Brooke M. Muscle biopsy: a modern approach. London: WB Saunders; 1973. p 98-102.
10. Dyck P, Chance P, Lebo R, Carney J. Hereditary motor and sensory neuropathies. In: Dyck P, Thomas P, eds. Peripheral neuropathy, 3rd ed. Philadelphia: WB Saunders; 1993. p 1094-1136.
11. Ericson U, Ansved T, Borg K. Charcot-Marie-Tooth disease type 1 and 2-an immunohistochemical study of muscle fiber cytoskeletal proteins and a marker for muscle fiber regeneration. Eur J Neurol 1998;5:545-551.
12. Greenhaff P. Creatine and its application as an ergogenic aid. Int J Sport Nutr 1995;5(Suppl):S100-S110.
13. Greenhaff P. The nutritional biochemistry of creatine. J Nutr Biochem 997;11:610-618.
14. Hanemann C, Muller H. Pathogenesis of Charcot-Marie-Tooth IA (CMTIA) neuropathy. Trends Neurosci 1998;21:282-286.
15. Harris R, Hultman E, Nordesjo L. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy sample of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest 1974;33:109-120.
16. Kilmer D. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 2002;81(Suppl):S121-126.
17. Klivenyi P, Ferrante R, Matthews R, Bogdanov M, Klein A, Andreassen O, Mueller G, Wermer M, Kaddurah-Daouk R, Beal M. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 1999;5:347-350.
18. Matthews R, Yang L, Jenkins B, Ferrante R, Rosen B, Kaddurah-Daouk R, Beal M. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 1998;18:156-163.
19. Nygaard E, Houston M, Suzuki Y, Jorgensen K, Saltin B. Morphology of the brachial biceps muscle and elbow flexion in man. Acta Physiol Scand 1983;117:287-292.
20. Persky A, Brazeau G. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 2001;53:161-176.
21. Pfeiffer G, Wicklein E, Ratusinski T, Schmitt L, Kunze K. Disability and quality of life in Charcot-Marie-Tooth disease type 1. J Neurol Neurosurg Psychiatry 2001;70:548-550.
22. Pollock M, Gaesser G, Butcher J, Despres J, Dishman R, Franklin B, Garber C. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998;30:975-991.
23. Reilly M. Genetically determined neuropathies. J Neurol 1998;245:6-13.
24. Schwid S, Thornton C, Pandya S, Manzur K, Sanjak M, Petrie M, McDermott M, Goodman A. Quantitative assessment of motor fatigue and strength in MS. Neurology 1999;53:743-750.
25. Stoll T, Huber E, Seifert B, Michel A, Stucki G. Maximal isometric muscle strength: normative values and gender-specific relation to age. Clin Rheumatol 2000;19:105-113.
26. Taaffe D, Pruitt L, Pyka G, Guido D, Marcus R. Comparative effects of high and low-intensity resistance training on thigh muscle strength, fiber area, and tissue composition in elderly women. Clin Physiol 1996;16:381-392.
27. Tarnopolsky M. Potential benefits of creatine monohydrate supplementation in the elderly. Curr Opin Clin Nutr Metab Care 2000;3:497-502.
28. Tarnolpolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999;52:854-857.
29. Tarnopolsky M, Parise G. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle Nerve 1999;22:1228-1233.
30. Wyss M, Felber S, Skladal D, Koller A, Kremser C, Sperl W. The therapeutic potential of oral creatine supplementation in muscle disease. Med Hypotheses 1998;51:333-336.